Dose-dependent toxicity of ipilimumab in metastatic melanoma.

Subjects

Subjects :

Adolescent
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Dose-Response Relationship, Drug
Gastrointestinal Diseases chemically induced
Gastrointestinal Diseases diagnosis
Humans
Male
Maximum Tolerated Dose
Melanoma pathology
Neoplasm Metastasis
Nivolumab administration & dosage
Nivolumab adverse effects
Skin Neoplasms drug therapy
Skin Neoplasms pathology
Ipilimumab administration & dosage
Ipilimumab adverse effects
Melanoma drug therapy
Neoplasms, Unknown Primary drug therapy

Details

Language :

English

ISSN :

1879-0852

Volume :

95

Database :

MEDLINE

Journal :

European journal of cancer (Oxford, England : 1990)

Publication Type :

Report

Accession number :

29477367

Full Text :

https://doi.org/10.1016/j.ejca.2018.01.088